Summary
To study the developmental pattern of chemotactic factor inactivator (CFI) activity, although avoiding the effects of labor and delivery, serial blood samples were obtained from eight chronically catheterized lamb fetuses, 13 pregnant, and 13 nonpregnant ewes. The biologic profiles of adult sheep neutrophils in response to sheep Co-derived chemotactic fractions (C5-e) were determined by the chemotactic and lysosomal enzyme release assays. CFI activity in sheep plasma was characterized and measured by the % inhibition of Cs-*-induced neutrophil lysosomal enzyme release.
The chernotactic and enzyme release profdes of sheep neutrophils paralleled those of human neutrophils. Sheep plasma was shown to contain a CFI-like activity similar to that in human plasma.
Mean CFI activity was higher in the plasma of pregnant ewes as compare to nonpregnant ewes (7.60 versus 5.15%, P < 0.001).
Higher CFI levels (39.5%) were shown in the plasma of chronically catheterized fetuses early in the third trimester of pregnancy (109 days gestational age). These fetal levels decreased progressively to attain normal adult levels at fetal maturity (147 days gestational age) and no significant changes were noted at or after birth. Because identical changes occurred in all chronicallv catheterized diated) and delayed (mononuclear-mediated) inflammatory reactions was decreased in patients with high CFI levels (18) . Thus, high CFI levels may contribute to an increased susceptibility to infections. The mechanisms whereby CFI inactivates chemotaxins remain obscure; CFI has clearly been shown to inactivate chemotactic factors such as C5.fr, bacterial-and lymphocyte-derived factors and some synthetic peptides (15, 19) . Although CFI activity did not directly alter leukocyte responsiveness to the chemotactic factors, we have recently demonstrated that product(s) of C5.fr inactivation by CFI inhibit neutrophil chemotactic and enzyme release responses to unaltered C5.fr (13) . Better understanding of the mechanisms and clinical relevance of CFI activity have been hampered by the difficulties in the purification of CFI (9) and the lack of animal model.
Our objectives in this paper were to describe an animal model for both the healthy adult and the neonate using adult ewes and chronically catheterized lamb fetuses. A CFI activity similar to that seen in the humans was demonstrated in fetal and adult sheep plasma. The effects of pregnancy on CFI levels were analyzed and CFI activity in the chronically catheterized fetus was serially tested and correlated with the gestational age.
fetuses, a developmentG pattern was defmed for C F~. Control CFI levels from six acutely catheterized fetuses did not differ from
MATERIALS AND METHODS
those predicted by the developmental Pattern. Thus, the changes Animal model. Nonpregnant and pregnant mixed breed Dorsetin CFI activity were not related to the ~hronic catheterization or S~ffolk ewes were obtained from local sources and housed at the to events surrounding labor and delivery; rather CFI levels corre-University of Iowa Animal Quarters throughout the study period. lated best with fetal immaturity.
The gestational ages of the fetuses were known based upon the CFI levels correlated inversely with ability of ZymOSan activated induced ovulation techniques (1, 7) . A heparinized catheter was plasma to induce neutro~hil chemotaxis (r = -0-%, P < 0.01), placed in the femoral artery of the fetuses at various gestational suggesting that CFI plays a major role in the regulation of ages under general anesthesia of the ewe (8) . A group of eight leukocytes chemotaxis.
fetuses were catheterized at the ages of 101-107 days and serially These data confirm previous findings in human neonates and evaluated. Another group of six fetuses was catheterized at the provide a model for future studies. Further studies into the biology ages of 124-137 days; however, only the blood samples obtained of the changes in CFI activity in the fetus and the influence of at surgery were tested in these actutely catheterized fetuses, to such high risk factors as prematurity, fetal distress or premature avoid the possible effects of chronic catheterization. rupture of membranes should enhance our understanding of the Blood collection. Venous blood was obtained from the ewes and immunocompromised neonate.
newborn lambs by venipuncture and mixed with sodium citrate (0.38% w/v final concentration). From catheterized fetuses the sample was collected via the catheter; 1 ml of blood was withdrawn
Complement activation in serum and plasma results in the to clear the catheter of saline, 9 rnl citrated blood was then generation of C5-derived chemotaxins (C5.fr) (2, 20) , which induce obtained as previously described (8) . Following delivery, blood neutrophil (2), monocyte (3) and lymphocyte chemotaxis (4) . samples were obtained from these lambs by venipuncture. Plasma Leukocyte chemotactic responses are dose-dependent (12), thus was removed by centrifugation at 1800 x g for 30 min and stored related to chemotatic factor generation, and can be adversely at -70°C in aliquots. Serum samples were similarly obtained after affected by the chemotactic factor inactivator (CFI) (13, 15, 17) allowing venous blood to clot at 22°C for 1 hr. and other chemotactic inhibitors (16) . CFI activity has been Preparations of neutrophil suspensions. Neutropohils were sepademonstrated in normal adult human plasma (5, 13) and serumd rated from citrated blood of adult nonpregnant ewes. Methods for (5, 17) . Higher levels were shown in patients with malignancies cell separation were similar to those used for human neutrophils (17) , liver disease (10) and in newborn infants (14) . The ability of (12, 13) with only minor changes: citrated venous blood was mixed activated human plasmas to induce neutrophil chemotaxis corre-(3:l v/v) with normal saline containing 2% Bovine serum albumin lated inversely with their CFI activity in both the adults and (BSA) and centrifuged at 300 X g for 15 min. The buffy coat was newborns ( r = -0.956, P < 0.001) (14) ; similarly, the ability to suspended in 10 ml saline, layered over a Ficoll-Hypaque gradient mobilize inflammatory cells in both the acute (neutrophil-me-and centrifuged at 300 X g for 45 min. Red blood cells were removed by hypotonic lysis and the neutrophils were washed once with 140 mM NaCl. All the above steps were performed at 4OC and resulted in 40% cell recovery, with >95% viable neutrophils by exclusion of trypan blue dye.
Neutrophils were suspended in Gey's solution, containing 2%
BSA at 50 x lo6 cells/ml when prepared for the chemotactic assays, and in Hank's balanced salt solution (HBSS) containing 4 pg/ml cytochalasin B at 10 x 106/ml when prepared for enzyme release inhibition assays (13) . Preparation of chemotaxins. Zymosan activated plasma (ZAP) and serum (ZAS) were prepared using standard techniques (6) . One mg zymosan in 0.1 ml H 2 0 was mixed with 1 ml sheep plasma or serum and incubated at 39OC for 30 min. Zymosan was then removed by centrifugation and the activated material was heated at 56°C for 30 min.
C5-derived chemotactic fractions (C5.fr) were also prepared using standard methods (5) . Pooled sheep serum was activated with zymosan in the presence of 1.0 M E-amino-n-caproic acid and the chemotactic fractions were separated by sephadex G-100 chromatography, concentrated to 4/2 the original volume and dialyzed against water. A batch of C5.fr was prepared, standardized by defining the quantities capable of inducing maximal chemotactic and enzyme release responses, then stored in aliquots at -70°C.
Chemotaxis under agarose. Previously described agarose tests (12) were used to quantify sheep neutrophil responses to sheep ZAP and C5.fr. In these assays, the gel contained 0.5% agarose and 2% BSA in Gey's solution. Three wells, 3 mm in diameter, 3 mm apart were made in a row. Ten pl cell suspensions containing 0.5
x lo6 neutrophils were placed in the lateral wells. The medial well received 20 pl of a mixture containing Gey's solution and 0, 6, 8, 10, 12, 14, 16, or 20 p1 C5.fr to determine the chemotactic doseresponse curve. In standard chemotactic assays, the medial well received 20 pl Gey's solution containing 0 or 10 p1 ZAP. Migration distances of neutrophils towards the central well in the presence or absence of C5.fr were determined after a 3 h incubation at 39OC to measure chemotaxis and spontaneous migration. The chemotactic differential (chemotaxis minus spontaneous migration) was used to define the chemotactic activity of a test sample. Results were expressed as % of the maximal response in the dose response assays and as % of the response to 10 pl of pooled ZAP in the standard assays. All assays were performed in quadruplicate.
Enzyme , at 39OC for 1 h. The reaction was stopped by adding I ml of glycine buffer (pH 10.5) and the absorbance was determined at 410 nrn. In these assays, 35 p1 of C5.fr constantly induced maximal enzyme release, consequently this quantity was used in enzyme release inhibition assays. Lysosomal enzyme release inhbition assays. CFI activity inhibits the C5.fr-induced neutrophil lysosomal enzyme release (5). This inhibition is dose-dependent, time-dependent and irreversible (5, 13) . Furthermore, CFI activity is heat labile. The enzyme release inhibition assay (5) was modified (13) to define CFI activity and its characteristics in adult and fetal plasma.
Dose-dependent curves were determined by premixing 35 y1 C5.fr with 115 HBSS containing plasma quantities equivalent to 0, 0.001, 0.01, 1.0, 2.0, and 10 p1. The mixtures were incubated at 39°C for 30 rnin then assayed for lysosomal enzyme release. Inhibition of lysosomal enzyme release was determined as follows:
LERmax
Where LER,,, was the enzyme release induced by 35 pl CCbfr and LER,,,,, the enzyme release induced by 35 pl C5.fr that had been preincubated with plasma.
The time dependency of the inhbition of C5.fr by plasma was determined by preincubating 35 p1 C5.fr with 115 p1 HBSS containing 10 p1 plasma for 0, 5, 10, 15, 20, 25 and 30 rnin at 39OC before testing for inhibition of lysosomal enzyme release. To evaluate the irreversible effects of CFI on C5.fr, the plasma-C5.fr mixture was incubated at 39OC for 30 min, then heated at 56OC for 120 rnin before testing for enzyme release inhibition. Finally, the heat lability of CFI in plasma was determined by preheating the plasma for 0-120 rnin before mixing with C5-fr. The mixtures were then preincubated at 39°C for 30 rnin and assayed for enzyme release inhibition.
Standard enzyme release inhibition assays were performed as previously described (13): 35 p1 CS.fr were preincubated with 0.01 p1 plasma in 115 p1 HBSS for 30 rnin at 39OC, then assayed for enzyme release inhibition. Thus, CFI activity in a test plasma was defined by the % inhibition of maximal enzyme release induced by 0.01 p1 plasma.
All enzyme release and enzyme release inhibition assays were run in triplicate.
Statistical methods. The two-sample t test was used to compare mean CFI levels in the plasma of pregnant and nonpregnant ewes. Polynomial regression was used to describe the relationship between CFI level and gestational age in the chronically catheterized fetuses. The residual S.D. was used to describe the variability about the regression line; this statistic estimates the variability of CFI level in these fetuses about the predicted mean CFI level for a given gestational age. The squared multiple correlation coefficient (3) is presented as a measure of the goodness-of-fit of the derived regression line; this statistic is interpreted as the proportion of variability which is explained by the regression. A value near 100% indicates that the maiority of the overall variability observed in CFI is accounted for (Gplaked) by the gestational age.
In order to determine whether chronic catheterization affected CFI levels, control data was obtained on six fetuses that were catheterized shortly before delivery. The observed values in these control animals were compared to values predicted from the regression equations developed on the chronically catheterized animals, using a one-sample t test on the differences between observed and predicted values. A nonsignificant t test indicates that, on the average, the deviations from predicted values were not different from zero, suggesting that chronic catheterization did not affect CFI levels in the fetus.
Pre-and postdelivery CFI levels were compared using the paired t test. The strength of the association between CFI level and the chemotactic activity of zymosan activated plasma was measured using the Pearson correlation coefficient.
RESULTS
Neutrophil dose-response curves in chemotaxis and lysosomal enzyme release assays. Neutrophils from three healthy nonpregnant ewes were assayed, on different days, in chemotaxis and enzyme release assays (Fig. 1) . Dose-response profiles were similar in both assays. Neutrophil responses increased sharply to a maximal level, then decreased as C5.fr concentrations were increased. Maximal responses always occurred at 14 p1 and 35 yl C5-fr respectively in the chemotaxis and enzyme release assays.
Maximal chemotactic responses (chemotactic differentials) varied between 2.2 and 2.4 mm and maximal lysosomal enzyme release responses varied between 0.220 and 0.260 absorbance units. S.D. of quadruplicate chemotactic measurements were within 6% of the mean, and S.D. of triplicate enzyme release measurements were within 5% of the mean. CFI activity in sheep plasma. As shown in Figure 2 , preincubation of C5.fr with plasma induced a dose-dependent inhibition of the chemotactic and lysosomal enzyme releasing activities. As previously shown in human plasma (13), the inhibition doseresponse curves were sigmoid with the linear segments corresponding to the logarithm of plasma quantities ranging between 0.01-1.0 pl. This inhibitory activity became apparent only after a at C5.fr. This was demonstrated further in Table 1 : when 2 p1 adult or fetal plasma were preincubated with Csfr, the enzyme releasing activity of C5.fr was totally inhibited (99-100%). However, minimal inhibition of the enzyme release was demonstrated when 10 pl adult or fetal plasma were preincubated with the neutrophils (7% with adult plasma and 5% with fetal plasma. Not statistically significant by the unpaired t test).
Heating the plasma at 56OC for 0-120 rnin before its preincubation with C5.fr resulted in a progressive loss of inhibitory activity in adult and fetal plasma. Virtually all inhibitory activity (97-98%) was lost after 110-120 min (Fig. 4 and Table 2 ). However, when the plasma was first incubated with C5-fr for 30 min at 39OC, then heated at 56OC for 120 min to destroy the inhibitory activity in the plasma, the inhibition of enzyme release was not reversed (Table 2) .
Thus, these studies demonstrated that, at the plasma concentrations used, the enzyme release inhibiting activity of adult sheep and fetal lamb plasma was heat labile, Cs.f,-directed, time-dependent and its effects were irreversible. These features are characteristic of CFI activity (5, 6, 14) . A difference in heat lability of CFI between adult and fetal plasma, similar to the difference in heat lability between human adult and newborn plasma (13, 14) , is seen. Reasons for this difference remain obscure and may be related to a difference in concentration (13, 14) .
CFZ levels in adult ewes, effects of pregnancy. CFI activity was measured in 13 nonpregnant ewes using plasma quantities equivalent to 0.01 p1. These plasmas inhibited enzyme release by 5.15% tion of the plasma-Cs.f, mixture was performed before adding the Fig. 3 . Inhibition, by plasma, of C5.f,-induced lysosomal enzyme release neutrophil suspension, these results suggested that neutrophil as a function of preincubation time at 39°C. Preincubation of Csfr with responsiveness was not directly affected by the presence of plasma plasma was performed before neutrophil suspensions were added. Each in the reaction mixture. Rather, the inhibitory activity was directed datapoint represents a mean of three experiments. ' 120 min at 56OC. tested on 5 different days, CFI activity was 3,4, 7, 5, and 3%. S.D. of triplicate measurements on the same day were constantly below 7% of the mean.
CFI activity in plasma from 13 pregnant ewes during the third trimester of pregnancy was higher than that in plasma of nonpregnant ewes (mean difference = 7.16% 2.1 1, t = 2.795, P < 0.001). However, while the means were significantly different, the data showed a great overlapping of CFI levels.
CFI levels in the fetus. CFI activity was determined in the plasma of eight chronically catheterized fetuses collected during the last 40 days of gestation; precisely between the age of 109 days and birth. As shown in Figure 5 , CFI levels ranged between 34-44% in the 109-day-old fetuses and decreased progressively thereafter to attain adult CFI levels (5%) in the term fetus (gestational age 147 days). Inasmuch as changes in CFI activity were similar in all fetuses, a developmental pattern was developed. Polynomial regression was used to develop a curve to predict CFI activity as a function of gestational age. Analyses indicated that a quadratic polynomial was the best fitting curve. The equation for this curve was: indicating that 93.3% of the variability in CFI activity was explained by the regression.
Effects of chronic catheterization. To determine whether changes in CFI activity during the third trimester of gestation were related to the chronic catheterization, another group of six fetuses was allowed to attain the gestational ages of 124, 125, 129, 132, and 137 days before catheterization. A blood sample was obtained during surgery from the femoral artrery of each fetus immediately after the catheter was placed. The CFI activity observed in each plasma sample was compared to the CFI activity predicted by the developmental pattern in the chronically catheterized fetuses, using a one-sample t test. The mean difference between predicted and observed values was 2.4 f 3.1 (mean f S.D.) yielding t = 1.879 (P = 0.12). Thus, the changes in CFI activity were not related to chronic catheterization.
Effects of labor and delivery. Delivery in the sheep occurs at about 145 days of gestation. Delivery of chronically catheterized fetuses occurred between 139-151 days. Blood samples were obtained by venipuncture within 24 h of birth. Plasma CFI activity was 6% f 4.5 (mean + S.D.) in the neonates and did not differ ~i g n~c a n t l y from CFI activity in fetal plasma that was obtained shortly before birth when compared by the paired t test. Thus, no significant changes in CFI activity were demonstrated in relation to either labor or delivery.
Correlation between CFZ activity and the chemotactic activity of activatedplasma. Ten plasma samples were tested for CFI activity, then activated with zymosan and tested for their ability to induce neutrophil chemotaxis. As shown in Figure 6 , a reciprocal relationship was shown between CFI and chemotactic activities (r = -0.96); this relationship was similar to that in human plasma (13, 14) .
DISCUSSION
Furthermore, the mechanisms whereby CFI is increased in both The development of chemotactic, enzyme releasing and enzyme-release inhibition assays has made possible the characterization of neutrophil dose-response profiles to CI.fr in the sheep, and the demonstration, characterization and quantitation of CFI activity in adult sheep, pregnant ewes and lamb fetuses. Furthermore, the use of the chronic fetal lamb model permitted studies of CFI changes during the third trimester of pregnancy. Profiles of the dose-response curves of adult nonpregnant sheep neutrophils to C5.fr (Fig. 1) paralleled those of human neutrophils (13) . CFI activity, defied by its heat lability (Fig. 2), time dependency (Fig.  3 ) and the irreversibility of its effects (Table 2 ) accounted for >98% of the (&,-directed inhibitory activity of adult sheep and fetal lamb plasma; similar results were previously obtained with human plasma (13, 14) . The lack of difference in CFI activity between the chronically catheterized and the acutely catheterized fetuses suggested that chronic catherization did not influence the developm%tal pattern of CFI activity. The pattern of development for CFI was similar in all eight fetuses as shown by the ability of a single regression curve to explain 93.3% of the changes in activity (Fig. 5) . Consequently, the sheep model can provide insight into the changes in CFI during fetal maturation.
CFI activity in human cord blood plasma was previously shown to be higher than that in human adult plasma and seemed to account for most of the difference in chemotactic activities between cord and adult plasmas (14) . The relationship of neonatal CFI levels to events surrounding labor and delivery and to maternal CFI levels remained obscure. The mechanisms whereby CFI activity is increased in the human neonate and the effects of labor and delivery, prematurity, and other neonatal high risk factors on CFI levels remain unknown.
Although CFI levels in pregnant ewes were higher than those in nonpregnant ewes, the amount of overlap was great. Conversely, CFI levels in the 109-day-old fetuses were significantly higher than and did not overlap with those in the mothers. These levels decreased steadily to attain normal adult levels in term fetuses and were unaffected by labor and delivery. Age of the fetus, determined by the induced ovulation technique (1, 7, 8) , correlated inversely with CFI activity in the fetus. This correlation accounted for 93.3% of the change in CFI activity, strongly suggesting that higher CFI activity is a function of fetal immaturity. When these results are applied to humans, CFI levels in the term neonates (14) are equivalent to those in the 127-day-old lamb fetuses.
The reciprocal relationship between CFI and chemotactic activity in sheep and human plasma (13, 14) clearly underlines the critical role CFI may play in the regulation of the inflammatory response. High CFI levels may play a role in the susceptibility of neonates to infections; however, other studies have demonstrated defects in neonatal host defenses at both the cellular and humoral levels. These studies, critically reviewed recently by M. E. Miller ( 1 l) , have demonstrated a defect in the movement and perhaps the phagocytic function of neonatal neutrophils. Movement of neonatal monocytes may also be deficient. At the humoral level, a decrease in bactericidal and opsonic activities against selected organisms was also demonstrated. Thus, the role of CFI levels in the susceptibility of neonates to infections is yet to be defied. mother and infant, and the effects of such risk factors as prematurity, fetal distress and premature rupture of membranes remain obscure. The chronically catheterized fetal lamb model can be used for such studies.
